Crohn's disease over 20 years after diagnosis in a referral population

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 12, 2004, Pages 1233-1239

  Etienney, Isabelle ^a   Bouhnik, Yoram ^a   Gendre, Jean Pierre ^b   Lémann, Marc ^c   Cosnes, Jacques ^b   Matuchansky, Claude ^a   Beaugerie, Laurent ^b   Modigliani, Robert ^c   Rambaud, Jean Claude ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b HÔPITAL ROTHSCHILD   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; SALAZOSULFAPYRIDINE;

ADENOCARCINOMA; ADOLESCENT; ADULT; ARTICLE; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; ILEUM CANCER; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; RELAPSE; RISK ASSESSMENT; SIDE EFFECT;

EID: 11244273044     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(04)95216-5     Document Type: Article

References (30)

1. Kornbluth A, Sachar DB, Salomon P. Crohn's disease. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Philadelphia: WB Saunders, 1998.
2. Cooke WT, Mallas E, Prior P, Allan RN. Crohn's disease: course, treatment and long term prognosis. Q J Med 1980:49:363-84.
3. Trnka YM, Glotzer DJ, Kasdon EJ, Goldman H, Steer ML, Goldman LD. The long-term outcome of restorative operation in Crohn's disease: influence of location, prognostic factors and surgical guidelines. Ann Surg 1982;196:345-55.
4. Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology 1985:88:1818-25.
5. Harper PH, Fazio VW, Lavery IC, Jagelman DG, Weakley FL, Farmer RG, et al. The long-term outcome in Crohn's disease. Dis Colon Rectum 1987;30:174-9.
6. Nordgren SR, Fasth SB, Oresland TO, Hulten LA. Long-term follow-up in Crohn's disease. Mortality, morbidity, and functional status. Scand J Gastroenterol 1994;29:1122-8.
7. Okada M, Sakurai T, Yao T, Iida M, Okabe N, Maeda K, et al. Clinical course and long-term prognosis of Crohn's disease in Japan. J Gastroenterol 1994;29:406-14.
8. Bouhnik Y, Lemann M, Mary JY, Scemama G, Tai R, Matuchansky C, et al. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 1996;347:215-9.
9. Bernades P, Hecketsweiler P, Benozio M, Descos L, Geffroy Y, Hemet J, et al. Proposition d'un système de critères pour le diagnostic des entérocolites inflammatoires cryptogénétiques (maladie de Crohn et rectocolite hémorragique). Une étude coopérative du GREC. Gastroenterol Clin Biol 1978;2:1047-54.
10. Colombel JF, Yazdanpanah Y, Laurent F, Houcke P, Delas N, Marquis P. Qualité de vie dans les maladies inflammatoires chroniques de l'intestin. Validation d'un questionnaire et premières données françaises. Gastroenterol Clin Biol 1996;20:1071-7.
11. Lapidus A, Bernell O, Hellers G, Lofberg R. Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients. Gastroenterology 1998;114:1151-60.
12. Cottone M, Rosselli M, Orlando A, Oliva L, Puleo A, Cappello M, et al. Smoking habits and recurrence in Crohn's disease. Gastroemerology 1994;106:643-8.
13. Greenstein AJ, Lachman P, Sachar DB, Springhorn J, Heimann T, Janowitz HD, et al. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 1988;29:588-92.
14. Binder V, Hendriksen C, Kreiner S. Prognosis in Crohn's disease - based on results from a regional patient group from the county of Copenhagen. Gut 1985;26:146-50.
15. Munkholm P, Langholz E, Davidsen M, Binder V. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol 1995;30:699-706.
16. Silverstein MD, Loftus EV, Sandborn WJ, Tremaine WJ, Feagan BG, Nieten PJ, et al. Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology 1999;117:49-57.
17. Hamon JF, Carbonnel F, Beaugerie L, Sezeur A, Gallot D, Malafosse M, et al. Comparison of long-term course of perforating and non-perforating Crohn disease. Gastroenterol Clin Biol 1998;22:601-6.
18. Sachar DB, Wolfson DM, Greenstein AJ, Goldberg J, Styczynski R, Janowitz HD. Risk factors for postoperative recurrence of Crohn's disease. Gastroenterology 1983;85:917-21.
19. De Dombal FT, Burton I, Goligher JC. Recurrence of Crohn's disease after primary excisional surgery. Gut 1971;12:519-27.
20. McDonald PJ, Fazio VW, Farmer RG, Jagelman DG, Lavery IC, Ruderman WB, et al. Perforating and nonperforating Crohn's disease. An unpredictable guide to recurrence after surgery. Dis Colon Rectum 1989;32:117-20.
21. Lautenbach E, Berlin JA, Lichtenstein GR. Risk factors for early postoperative recurrence of Crohn's disease. Gastroenterology 1998;115:259-67.
22. Collier PE, Turowski P, Diamond DL. Small intestinal adenocarcinoma complicating regional enteritis. Cancer 1985;55:516-21.
23. Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994;35:1590-2.
24. Sacova PE, Garth HB, Elton C. Gastrointestinal malignancies in Crohn's disease: a 20 year experience. Dis Col Rect 1990;33:7-11.
25. Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001;91:854-62.
26. Jess T, Winther KV, Munkholm P, Langholz E, Binder V. Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Gastroenterology 2002;122:1808-14.
27. Ekbom A, Helmick CG, Zack M, Holmberg L, Adami HO. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology 1992;103:954-60.
28. Persson PG, Bernell O, Leijonmarck CE, Farahmand BY, Hellers G, Ahlbom A. Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology 1996;110:1339-45.
29. Markowitz J, Grancher K, Kohn N, Lesser M, Daum F. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000;119:895-902.
30. Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 2000;343:1594-602.